Although they showed no skin irritation or skin-related sensitization in rabbits or guinea pigs, their toxicity response for a long time must be conducted to use this material confidentially in clinical practice
Allowing compounding pharmacies to produce these peptides does not change their status as unapproved drugs, does not mean clinical trials have been conducted, and does not mean the FDA has evaluated them for safety or efficacy in humans
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
in animal studies, the peptide has a positive effect on aged mice, demonstrating significant increases in their activity and health, as well as some positive visual changes in their fur
doi: 10.21873/invivo.12488, 93